Back to Agenda
S21 : Exploring IRBs with a Global Twist!
Session Chair(s)
Kiyomi Hirayama, PHD
Senior Director, Quality Management Unit Japan Development, MSD K.K., Japan
Speaker(s)
Jan Hewett, BSN, JD
SVP, FDA Regulatory Advisor, Advarra, United States
Rebecca Boesenberg
Study Start-up Team Lead, AUS & NZ, Study and Site Operations, Novartis Pharmaceuticals, Australia
Fung-Wei Chang
President, Taiwan Association of Institutional Review Boards, Taiwan
IRB in Taiwan - Collaborative IRB Process and IRB Inspection
Naoto Uemura, MD, PHD
Professor and Head of Clinical Pharmacology and General Clinical Research Center, Oita University Faculty of Medicine, Japan
Yusuke Fukuda
Dupty Director, Pharmaceutical Evaluationand Management Division , Ministry of Health, Labour and Welfare (MHLW), Japan
Have an account?